Hilton Head Capital Partners »

Trevi Therapeutics shares owned by Hilton Head Capital Partners

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Hilton Head Capital Partners from 13F filings

Historical chart of Hilton Head Capital Partners investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Hilton Head Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Hilton Head Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $81k 4.4k 18.65
2026-03-31 $51k 4.3k 11.93

More positions owned by Hilton Head Capital Partners

First Trust Etf Iv First Trust Enhanced Short First Tr Enh New (FTSM)
Shelton Equity Premium Income Etf Shelton Eqt Pre (SEPI)
Eli Lilly & Co. (LLY)
Lam Research Corporation Com New (LRCX)
Ft Vest Laddered Buffer Etf Ft Ladd Buff Etf (BUFR)
First Trust Nasdaq Rising Dividend Achievers Risng Divd Achiv (RDVY)
Schwab Us Dividend Equity Etf Us Dividend Eq (SCHD)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Microsoft Corporation (MSFT)
Philip Morris International (PM)
Avantis International Equity Etf Intl Eqt Etf (AVDE)
Wal-Mart Stores (WMT)
Arm Holdings Sponsored Ads (ARM)

View all positions for Hilton Head Capital Partners

Top funds holding Trevi Therapeutics

NEA Management Company
FMR
BlackRock
Frazier Life Sciences Management
Wellington Management Company
Vanguard Capital Management
Vivo Capital
Woodline Partners
Vestal Point Capital
MPM Oncology Impact Management
Frontier Capital Management
Geode Capital Management
Marshall Wace
State Street Corporation
Eventide Asset Management

View all funds holding Trevi Therapeutics